 |
|
 |
 |

Home > Company Index > Drugs > Drug Delivery > Cellegy Pharmaceuticals, Inc.
 |
Cellegy Pharmaceuticals, Inc. |
 |
 |
 |
PROFILE |
 |
Cellegy Pharmaceuticals is developing prescription topical pharmaceuticals, consumer skin care products, and transdermal drug delivery technologies. Its lead candidate, Anogesic, treats hemorrhoids. Other products in development include hormone therapies for men and women and a treatment for severe dry skin. Accounting for almost 90% of the company's sale, its consumer "cosmeceutical" products include C79 Intensive Moisturizer, an anti-wrinkle formula Cellegy has licensed to a specialty retailer for use in its hand creams. The company bought Australia's Quay Pharmaceuticals, which makes an anal fissure ointment. Cellegy plans to market in other Pacific Rim countries.
COMPETITION |
 |
Bioglan Pharma Plc (BGP)
Medicis Pharmaceutical Corporation (MRX)
|
 |
STOCK ANALYSIS |
 |
FURTHER ANALYSIS
Advanced Charting
Deals
FINANCIAL OVERVIEW |
 |
Fiscal Year-End: December
2000 Sales (mil.): 1.60
1-Yr. Sales Growth: 60.0%
Employees: 32
Revenue per employee: $50,000.00
KEY PEOPLE |
 |
K. Michael Forrest
CEO
A. Richard Juelis
CFO
CONTACT INFO |
 |
349 Oyster Point Blvd., Ste. 200
S. San Francisco, CA 94080
US
Phone: 650-616-2200
Fax: 650-616-2222
Online: Web Site
|
 |
 |
 |
|
Hoover's Company Capsule
Copyright © 2001, Hoover's Inc. Austin, Texas.
For changes and updates, contact Hoover's directly.
|

|
 |
 |
|
 |